In sporadic non-heritable cancers MSI is the consequence of either inactivating mutations in one of the MMR's genes, or epigenetic mechanisms of MMR gene expression including down regulation by microRNAs (Gelsomino et al., 2016). This evidence concerns the gene MRC1 and cancer.